International Stem Cell CORP Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
International Stem Cell CORP quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • International Stem Cell CORP Return On Equity for the quarter ending September 30, 2024 was 16.4 %.
  • International Stem Cell CORP annual Return On Equity for 2023 was 3.21 %, a 56.2% decline from 2022.
  • International Stem Cell CORP annual Return On Equity for 2022 was 7.32 %, a 63.5% decline from 2021.
  • International Stem Cell CORP annual Return On Equity for 2021 was 20 %, a 73.1% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 16.4 +24.8 Jul 1, 2024 Sep 30, 2024
Q2 2024 16.8 +19.9 Apr 1, 2024 Jun 30, 2024
Q1 2024 7.7 -0.2 -2.53% Jan 1, 2024 Mar 31, 2024
Q4 2023 3.21 -4.11 -56.2% Oct 1, 2023 Dec 31, 2023
Q3 2023 -8.4 -23.9 -154% Jul 1, 2023 Sep 30, 2023
Q2 2023 -3.16 -15 Apr 1, 2023 Jun 30, 2023
Q1 2023 7.9 +0.94 +13.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 7.32 -12.7 -63.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 15.5 -13.2 -45.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 11.8* -26.5 Apr 1, 2022 Jun 30, 2022
Q1 2022 6.96 -64.5 -90.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 20 -54.3 -73.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 28.7 -114 -79.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 38.3 -128 -77% Apr 1, 2021 Jun 30, 2021
Q1 2021 71.5 -125 -63.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 74.3 -216 -74.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 143 -2.18K Jul 1, 2020 Sep 30, 2020
Q2 2020 167 +493 Apr 1, 2020 Jun 30, 2020
Q1 2020 196 +347 Jan 1, 2020 Mar 31, 2020
Q4 2019 291 +390 Oct 1, 2019 Dec 31, 2019
Q3 2019 2.32K* +2.45K Jul 1, 2019 Sep 30, 2019
Q2 2019 -326 +44.1 +11.9% Apr 1, 2019 Jun 30, 2019
Q1 2019 -151 +148 +49.5% Jan 1, 2019 Mar 31, 2019
Q4 2018 -99.1 +492 +83.2% Oct 1, 2018 Dec 31, 2018
Q3 2018 -123 +61 +33.2% Jul 1, 2018 Sep 30, 2018
Q2 2018 -370 -374 -9672% Apr 1, 2018 Jun 30, 2018
Q1 2018 -299 -1.48K -125% Jan 1, 2018 Mar 31, 2018
Q4 2017 -591 -634 -1464% Oct 1, 2017 Dec 31, 2017
Q3 2017 -184 -345 -214% Jul 1, 2017 Sep 30, 2017
Q2 2017 3.87 -197 -98.1% Apr 1, 2017 Jun 30, 2017
Q1 2017 1.18K +519 +78.4% Jan 1, 2017 Mar 31, 2017
Q4 2016 43.3 +377 Oct 1, 2016 Dec 31, 2016
Q3 2016 162 +1.37K Jul 1, 2016 Sep 30, 2016
Q2 2016 201 +14.5K Apr 1, 2016 Jun 30, 2016
Q1 2016 662 -4.43K -87% Jan 1, 2016 Mar 31, 2016
Q4 2015 -334 -1.29K -135% Oct 1, 2015 Dec 31, 2015
Q3 2015 -1.21K -1.65K -378% Jul 1, 2015 Sep 30, 2015
Q2 2015 -14.3K -14.7K -3945% Apr 1, 2015 Jun 30, 2015
Q1 2015 5.09K +4.81K +1694% Jan 1, 2015 Mar 31, 2015
Q4 2014 955 +526 +122% Oct 1, 2014 Dec 31, 2014
Q3 2014 436 -129 -22.8% Jul 1, 2014 Sep 30, 2014
Q2 2014 373 -907 -70.9% Apr 1, 2014 Jun 30, 2014
Q1 2014 284 +9.82K Jan 1, 2014 Mar 31, 2014
Q4 2013 429 +1.48K Oct 1, 2013 Dec 31, 2013
Q3 2013 565 +996 Jul 1, 2013 Sep 30, 2013
Q2 2013 1.28K +1.57K Apr 1, 2013 Jun 30, 2013
Q1 2013 -9.54K -9.3K -3908% Jan 1, 2013 Mar 31, 2013
Q4 2012 -1.05K Oct 1, 2012 Dec 31, 2012
Q3 2012 -431 Jul 1, 2012 Sep 30, 2012
Q2 2012 -294 Apr 1, 2012 Jun 30, 2012
Q1 2012 -238 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.